Valuation: IXICO plc

Market Cap 1.64Cr 2.17Cr 1.91Cr 1.8Cr 3.07Cr 208.41Cr 3.1Cr 22Cr 8.35Cr 106.47Cr 8.16Cr 7.99Cr 342.2Cr P/E 2026 *
-5.36x
P/E 2027 * -5.77x
Enterprise Value 62.23L 82.4L 72.3L 68.29L 1.16Cr 79Cr 1.17Cr 8.17Cr 3.17Cr 40Cr 3.09Cr 3.03Cr 129.67Cr EV / Sales 2026 *
0.78x
EV / Sales 2027 * 1.15x
Free-Float
89.22%
Yield 2026 *
-
Yield 2027 * -
Current month-3.23%
1 month-3.23%
3 months-11.24%
6 months-4.76%
Current year-36.17%
1 week 7
Extreme 7
8
1 month 7
Extreme 7
8
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
19.5
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 19/08/2024
Director of Finance/CFO 50 21/08/2019
Chief Tech/Sci/R&D Officer - 01/06/2025
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 21/08/2019
Director/Board Member 60 21/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
15/07/26 Buy

Chairman

50,006 0.0228%
13/06/25 Free 3,50,000 0.3777%
13/06/25 Free 3,50,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-45.45%-61.34% 2.17Cr
+2.64%+6.45%+12.39%+38.40% 4.8TCr
+0.14%+0.34%+49.85%+36.98% 4.45TCr
-0.69%+5.89%+343.04%+622.77% 4.39TCr
+1.13%+0.04%+9.91%+98.64% 4.1TCr
+0.51%-0.61%+5.18%+46.87% 2.99TCr
-0.54%-1.63%+22.62%+149.24% 1.73TCr
-0.16%+9.00%+8.25% - 1.53TCr
+1.76%+0.85%+29.47%+48.42% 1.53TCr
+1.83%-3.37% - - 1.48TCr
Average +0.60%+2.22%+48.36%+122.50% 2.7TCr
Weighted average by Cap. +0.68%+2.97%+76.06%+165.12%

Financials

2026 *2027 *
Net sales 80L 1.06Cr 92.95L 87.79L 1.5Cr 101.52Cr 1.51Cr 11Cr 4.07Cr 52Cr 3.98Cr 3.89Cr 166.69Cr 90L 1.19Cr 1.05Cr 98.76L 1.68Cr 114.21Cr 1.7Cr 12Cr 4.58Cr 58Cr 4.47Cr 4.38Cr 187.53Cr
Net income -21.43L -28.37L -24.9L -23.52L -40.12L -27Cr -40.4L -2.81Cr -1.09Cr -14Cr -1.07Cr -1.04Cr -45Cr -28.01L -37.09L -32.54L -30.74L -52.43L -36Cr -52.81L -3.68Cr -1.42Cr -18Cr -1.39Cr -1.36Cr -58Cr
Net Debt -1.02Cr -1.35Cr -1.19Cr -1.12Cr -1.91Cr -129.44Cr -1.92Cr -13Cr -5.19Cr -66Cr -5.07Cr -4.96Cr -212.53Cr -61L -80.77L -70.87L -66.94L -1.14Cr -77Cr -1.15Cr -8.01Cr -3.1Cr -40Cr -3.03Cr -2.97Cr -127.1Cr
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
28/26/28 GBX 7.500 0.00% 14,537
25/26/25 GBX 7.500 0.00% 12,529
24/26/24 GBX 7.500 +1.35% 1,06,916
23/26/23 GBX 7.400 -1.33% 2,35,066
22/26/22 GBX 7.500 0.00% 95,108
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750GBP
Average target price
0.2600GBP
Spread / Average Target
+246.67%

Annual profits - Rate of surprise